Chemed

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Chemed Corporation's Q1 2023 Earnings Call Highlights Strong Performance and Growth Opportunities

Chemed Corporation's Q1 2023 earnings call showcased strong financial performance, operational resilience, and strategic workforce expansion. While concerns about reimbursement and billing limitations exist, the company is well-positioned to capitalize on growth opportunities and sustain its current success.

Chemed Corporation's VITAS Segment Shows Strong Operational Improvement Post-Pandemic

Chemed Corporation's Q2 2023 earnings call highlighted VITAS' strong operational improvement and revenue growth, while Roto-Rooter faced challenges in demand generation. Both segments are cautiously optimistic about the future and are implementing strategies to address their respective challenges.

CHE reports strong Q3 earnings, anticipates growth amid challenges

VITAS demonstrated robust growth in admissions and net revenue, while Roto-Rooter offset decreased call volume with improved conversion rates. Both segments face challenges in consumer spending impact and comparison to previous quarters, but anticipate growth opportunities in 2024.

CHE reports mixed Q1 results with VITAS growth and Roto-Rooter challenges

VITAS excelled in revenue growth and workforce expansion, while Roto-Rooter faced challenges with declining call volume and EBITDA. Strategic actions are being taken to address weaknesses and capitalize on growth opportunities. Both companies remain optimistic about future acquisitions and growth potential.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chemed (CHE) delivered earnings and revenue surprises of 4.53% and -0.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Q3 Earnings Beat Estimates

Investors continue to be optimistic about Chemed's (CHE) performance.

Here's Why You Should Hold on to Chemed (CHE) Stock Right Now

The "modern" Chemed emerged in 2004 with its two cash-cow subsidiaries: VITAS and Roto-Rooter.

Chemed: 2 Boring Cash Cows Make A Great Company

Federal Signal

MDU Resources Group

Gibraltar Industries

SolarEdge Technologies

With Q3 reporting season knocking on the door, investors are eyeing stocks that exhibited solid earnings growth in the prior quarters. But one should consider the stocks' debt levels before investing.

Buy These 5 Low Leverage Stocks to Stay Afloat in Crisis

American States Water

Hanger Inc

Pilgrim's Pride

Purple Innovation

5 Defensive Stocks to Guard Against Economic Slow Down

FTI Consulting

L3Harris

Statistically, companies prefer debt over equity since debt is easily available and cheaper than equity. Yet, debt ridden companies are more prone to bankruptcy in times of crisis.

Buy These 5 Low Leverage Stocks if You Want to Avoid Risk

Industrial Logistics Properties

iStar Inc

AquaVenture Holdings

Global economic slowdown is the major concern of Fed. The European Central Bank recently injected stimulus like rate cut and quantitative easing to restore growth in the Eurozone economy.

Fed May Cut Rate Again Despite Stable Economy: 5 Picks

Here's Why You Should Invest in Chemed (CHE) Stock Right Now

Arbor Realty Trust

DaVita

Viad Corp

Exantas Capital Corp

The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite heightened trade conflict and global economic slowdown.

Strong ISM Services Index Eases Recession Fears: 5 Top Picks

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Chemed (CHE) Up 13.4% Since Last Earnings Report: Can It Continue?

president and CEO of Chemed Corp (30-Year Financial, Insider Trades) Kevin J Mcnamara (insider trades) sold 5,000 shares of CHE on 08/22/2019 at an average price of $432.73 a share.

Chemed Corp (CHE) president and CEO Kevin J Mcnamara Sold $2.2 million of Shares

Amedisys

LHC Group

Outlook for Outpatient and Home Healthcare Industry Looks Bright

Alamos Gold

Franco-Nevada C

Throughout this month, U.S. stock markets are witnessing extreme volatility.

5 Safe Picks Amid Yield Inversion and Geopolitical Concerns

executive vice president & CFO of Chemed Corp (30-Year Financial, Insider Trades) David Patrick Williams (insider trades) sold 17,979 shares of CHE on 08/12/2019 at an average price of $430.8 a share.

Chemed Corp (CHE) executive vice president & CFO David Patrick Williams Sold $7..

president and CEO of Chemed Corp (30-Year Financial, Insider Trades) Kevin J Mcnamara (insider trades) sold 12,000 shares of CHE on 08/07/2019 at an average price of $416.8 a share.

Chemed Corp (CHE) president and CEO Kevin J Mcnamara Sold $5 million of Shares

TopBuild

James River Group Holdings

Herman Miller

Oasis Midstream Partners

Since existence of a debt-free company is rare, the real challenge for an investor is determining whether an organization???s debt level is sustainable.

Buy These 5 Low Leverage Stocks to Keep Your Portfolio Secure

Does Chemed (CHE) have what it takes to be a top stock pick for momentum investors? Let's find out.

Chemed (CHE) is a Great Momentum Stock: Should You Buy?

Chemed Corporation (CHE) CEO Kevin McNamara on Q2 2019 Results - Earnings Call Transcript

It is encouraging to note that Chemed (CHE) witnessed solid revenue growth across both of its key subsidiaries.

Chemed (CHE) Earnings Top Estimates in Q2, Margins Expand

Chemed (CHE) delivered earnings and revenue surprises of 8.74% and 0.80%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Tops Q2 Earnings and Revenue Estimates

Chemed's (CHE) VITAS shows higher adoption via an expanded average daily census. Also, the Roto-Rooter's business grows on the back of strong core plumbing and drain cleaning service segments.

Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak

Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.

News for Chemed Stock (CHE)